Your browser doesn't support javascript.
loading
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer.
Wieser, Verena; Gaugg, Inge; Fleischer, Martina; Shivalingaiah, Giridhar; Wenzel, Soeren; Sprung, Susanne; Lax, Sigurd F; Zeimet, Alain G; Fiegl, Heidelinde; Marth, Christian.
Afiliação
  • Wieser V; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Gaugg I; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Fleischer M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Shivalingaiah G; Division of Human Genetics, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Wenzel S; Present address: Division Biological Chemistry, Biocenter, Innsbruck, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Sprung S; Division of Human Genetics, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Lax SF; Institute of Pathology, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Zeimet AG; Department of Pathology, Hospital Graz Süd-West, Academic Teaching Hospital of the Medical University Graz, Graz 8020, Austria.
  • Fiegl H; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Marth C; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck 6020, Austria.
Oncotarget ; 9(25): 17501-17511, 2018 Apr 03.
Article em En | MEDLINE | ID: mdl-29707124
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article